Tallas Biotech Inc.
Tallas Biotech focuses on RNAi-based drug discovery for pre-clinical targets. It employs a proprietary multi-wheel AI research platform to identify synthetic RNAi molecules as drug targets. This B2B biotech discovery platform serves pharmaceutical and biotech researchers in inflammation and pain. The company aims to accelerate target discovery and pipeline development in the pre-clinical stage through AI-driven approaches.
Tallas Biotech Inc.
Tallas Biotech focuses on RNAi-based drug discovery for pre-clinical targets. It employs a proprietary multi-wheel AI research platform to identify synthetic RNAi molecules as drug targets. This B2B biotech discovery platform serves pharmaceutical and biotech researchers in inflammation and pain. The company aims to accelerate target discovery and pipeline development in the pre-clinical stage through AI-driven approaches.